Vallon Pharmaceuticals, Inc.

NasdaqCM:VLON Stock Report

Market Cap: US$5.4m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Vallon Pharmaceuticals Management

Management criteria checks 0/4

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Vallon Pharmaceuticals reports Q2 results

Jul 28

We're Keeping An Eye On Vallon Pharmaceuticals' (NASDAQ:VLON) Cash Burn Rate

Dec 15
We're Keeping An Eye On Vallon Pharmaceuticals' (NASDAQ:VLON) Cash Burn Rate

We Think Vallon Pharmaceuticals (NASDAQ:VLON) Needs To Drive Business Growth Carefully

Aug 17
We Think Vallon Pharmaceuticals (NASDAQ:VLON) Needs To Drive Business Growth Carefully

Will Vallon Pharmaceuticals (NASDAQ:VLON) Spend Its Cash Wisely?

May 17
Will Vallon Pharmaceuticals (NASDAQ:VLON) Spend Its Cash Wisely?

CEO

Vallon Pharmaceuticals has no CEO, or we have no data on them.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.